No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adolescent
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / genetics*
-
Cohort Studies
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Drug Resistance, Neoplasm / genetics*
-
Female
-
Follow-Up Studies
-
Gene Expression Profiling*
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / mortality*
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local / drug therapy
-
Neoplasm Recurrence, Local / genetics
-
Neoplasm Recurrence, Local / mortality
-
Neoplasm Staging
-
Prognosis
-
Survival Rate
-
Young Adult
Substances
-
Biomarkers, Tumor
-
Cytarabine
-
Daunorubicin
Associated data
-
ClinicalTrials.gov/NCT00049517